The YEARS Study – Simplified Diagnostic Management of PE

The YEARS Study – Simplified Diagnostic Management of PE

The clinical diagnosis of pulmonary embolism (PE) can be challenging given its variable presentation, requiring dependence on objective testing. Decision instruments such as PERC and the Wells' score help stratify patients... read more

FDA approves betrixaban for VTE prophylaxis

FDA approves betrixaban for VTE prophylaxis

Betrixaban, a factor Xa inhibitor, has been approved for the prophylaxis of venous thromboembolism (VTE) in at-risk adult patients hospitalized with an acute illness, according to an announcement from the Food and Drug Administration.... read more

Venous Thromboembolism Prophylaxis in Major Orthopedic Surgery

Venous Thromboembolism Prophylaxis in Major Orthopedic Surgery

Few head-to-head treatment comparisons have sufficient evidence. Most studies evaluated low molecular weight heparin (LMWH), not low-risk interventions (such as aspirin and mechanical devices); most reported on total deep... read more

Principles learned from a successful VTE improvement program

Principles learned from a successful VTE improvement program

Principles learned from a successful improvement program can increase compliance and reduce hospital acquired VTEs (HA-VTEs) across multiple institutions. Can a single institution’s VTE prophylaxis program be scaled to... read more

Thromboprophylaxis after Knee Arthroscopy and Lower-Leg Casting

Thromboprophylaxis after Knee Arthroscopy and Lower-Leg Casting

The results of our trials showed that prophylaxis with low-molecular-weight heparin for the 8 days after knee arthroscopy or during the full period of immobilization due to casting was not effective for the prevention of... read more

GCA independently raises risk for VTE

GCA independently raises risk for VTE

The risk of venous thromboembolism (VTE) increases markedly shortly before the diagnosis of giant cell arteritis (GCA) regardless of glucocorticoid exposure, peaks at the time of diagnosis, and then progressively declines,... read more

Testosterone VTE Risk; Novel Clot Buster Flops Again; Saturated Fat Culpability

Testosterone VTE Risk; Novel Clot Buster Flops Again; Saturated Fat Culpability

The venous thromboembolism (VTE) risk warned about with testosterone treatment appears to be transient, peaking within 6 months after starting and then gradually declining.... read more

New Clinical Resources From American Association Of Critical-Care Nurses Address Delirium, CAUTI And VTE

New Clinical Resources From American Association Of Critical-Care Nurses Address Delirium, CAUTI And VTE

Updated AACN Practice Alerts offer latest evidence-based practice related to delirium, catheter-associated urinary tract infections and venous thromboembolism.... read more

VTE history in female relatives increases absolute thrombotic risk

VTE history in female relatives increases absolute thrombotic risk

A family history of thrombosis in women may increase the risk for venous thromboembolism in women taking oral contraceptives, according to the results of a cohort study.... read more